Your support in 2019 helped us reach these milestones
Each year has been an opportunity to see strides made in lung cancer research. Here’s a glimpse at what accomplishments you helped the LCFA team toward our mission:
lung cancer community
Shared milestone lung cancer stories
Over 180,000 website visits to read survivor stories – an 84% increase.
Stories of inspirational people living with lung cancer. Testimonies illustrating how research breakthroughs in lung cancer diagnosis and treatment are changing the lives of people diagnosed with lung cancer.
Funded more grants for lung cancer research
In 2019, in partnership with the International Association for the Study of Lung Cancer and Bristol-Myers Squibb, LCFA funded $400,000 in lung cancer research grants.
Meet the Young Investigators of 2019:
In our decade-plus history, LCFA has been able to award over $4 million in lung cancer research grants. Watch for additional new grants and scholarships in 2020.
latest research education
Added additional topics in informative video series
Launched in 2018, Hope With Answers℠, an on-demand video series you can watch anytime, anywhere, expanded the series with 10 new topics this year. These videos feature lung cancer patients consulting with leading lung cancer doctors in understandable language and 3 levels of detail.
Covering important topics of lung cancer research, diagnosis, and treatment, LCFA expanded the series by 28 new videos in 2019. Patients, doctors, and researchers discuss topics like Thoracic Surgery, Valid Lung Cancer Research, and CBD and Lung Cancer.
Drawing in 14.6K Users to our YouTube Channel, LCFA comprehensive educational videos got 163,317 views in 2019. Hope With Answers℠ videos accounted for over 150K views in 2019.
lung cancer awareness
Amplified our awareness messaging
lung cancer awareness
As a result, LCFA is staying on course for funding impactful lung cancer research by:
- The innovative partnership with IASLC to fund young investigators in lung cancer research since 2012.
- Building a network of leading lung cancer doctors to help educate and explain the latest research and clinical trials.